Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 269
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Efficacy of voriconazole on leishmaniasis by Leishmania major: An in vitro and in vivo study

Oryan Ahmad, Bahrami Somayeh, Bemani Effat

Year : 2018| Volume: 11| Issue : 10 | Page no: 562-569

   This article has been cited by
 
1 Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review
Rajamanthrilage Kasun Madusanka, Hermali Silva, Nadira D. Karunaweera
Infectious Diseases and Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Fabrication and Evaluation of Voriconazole Loaded Transethosomal Gel for Enhanced Antifungal and Antileishmanial Activity
Mudassir Farooq, Faisal Usman, Sumera Zaib, Hamid Saeed Shah, Qazi Adnan Jamil, Fatima Akbar Sheikh, Ajmal Khan, Sameh Rabea, Soheir A. A. Hagras, Gaber El-Saber Batiha, Imtiaz Khan
Molecules. 2022; 27(10): 3347
[Pubmed]  [Google Scholar] [DOI]
3 Exploring Innovative Leishmaniasis Treatment: Drug Targets from Pre-Clinical to Clinical Findings
Wanessa Santana,Simone S. C. Oliveira,Mariana H. Ramos,André L. S. Santos,Silvio S. Dolabella,Eliana B. Souto,Patrícia Severino,Sona Jain
Chemistry & Biodiversity. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Efficacy of amiodarone and voriconazole combination therapy in cutaneous leishmaniasis in the mice experimentally infected with Leishmania major
S. Bahrami,A. Oryan,E. Bemani
Journal of Infection and Chemotherapy. 2021;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article